SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001485003-22-000155
Filing Date
2022-11-07
Accepted
2022-11-07 08:00:45
Documents
10

Document Format Files

Seq Description Document Type Size
1 425 sesnform3q2022earningsrele.htm 425 27198
2 EX-99.1 ex991_3q2022earningsrele.htm EX-99.1 31716
3 ex991_3q2022earningsrele001.jpg GRAPHIC 239851
4 ex991_3q2022earningsrele002.jpg GRAPHIC 284016
5 ex991_3q2022earningsrele003.jpg GRAPHIC 308628
6 ex991_3q2022earningsrele004.jpg GRAPHIC 335579
7 ex991_3q2022earningsrele005.jpg GRAPHIC 337503
8 ex991_3q2022earningsrele006.jpg GRAPHIC 224405
9 ex991_3q2022earningsrele007.jpg GRAPHIC 150442
10 ex991_3q2022earningsrele008.jpg GRAPHIC 143904
  Complete submission text file 0001485003-22-000155.txt   2849611
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filed by) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36296 | Film No.: 221363779
SIC: 2834 Pharmaceutical Preparations